Тёмный

CMC Considerations for Biotechnology Product Development: A Regulatory Perspective 

U.S. Food and Drug Administration
Подписаться 166 тыс.
Просмотров 2,9 тыс.
50% 1

FDA discusses regulatory expectations for biotechnology products, regulatory challenges, and strategies for success.
Presenters:
Wendy Weinberg, PhD, Chief, Laboratory of Molecular Oncology
Kristen Nickens, PhD, Product Quality Team Lead
Office of Biotechnology Products (OBP), Office of Pharmaceutical Quality (OPQ), CDER
Learn more at: www.fda.gov/dr...
-------------------- 
FDA CDER’s Small Business and Industry Assistance (SBIA) educates and provides assistance in understanding the regulatory aspects of human drug products & clinical research.  
Upcoming Training - www.fda.gov/cd...
SBIA Listserv - public.govdeli...
SBIA 2021 Playlist - • 2021 CDER Small Busine...
SBIA LinkedIn - / cder-small-business-an...
SBIA Training Resources - www.fda.gov/cd...
Twitter - / fda_drug_info  
Email - CDERSBIA@fda.hhs.gov  
Phone - (301) 796-6707 I (866) 405-5367

Опубликовано:

 

9 июл 2024

Поделиться:

Ссылка:

Скачать:

Готовим ссылку...

Добавить в:

Мой плейлист
Посмотреть позже
Комментарии    
Далее
Mcdonalds cups and ball trick 🤯🥤 #shorts
00:25
Просмотров 1,6 млн
Electronic Common Technical Document (eCTD)
46:23
Просмотров 11 тыс.
Navigating the Quality Management System Regulation
22:26
An Overview of the Quality Management System Regulation
16:15
Sickle Cell Disease: A Spotlight on Women
1:00:38
Mcdonalds cups and ball trick 🤯🥤 #shorts
00:25
Просмотров 1,6 млн